Net Cash Provided by (Used in) Financing Activities in USD of IVERIC bio, Inc. from 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IVERIC bio, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2015 to Q1 2023.
  • IVERIC bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $2,589,000, a 24% increase year-over-year.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $428,905,000, a 57% increase from 2021.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $272,335,000, a 81% increase from 2020.
  • IVERIC bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $150,581,000, a 252% increase from 2019.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

IVERIC bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $2,589,000 +$509,000 +24% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q1 2022 $2,080,000 +$1,951,000 +1512% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $129,000 -$50,000 -28% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $179,000 +$138,000 +337% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $41,000 +$14,000 +52% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $27,000 -$4,000 -13% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $31,000 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1

IVERIC bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $428,905,000 +$156,570,000 +57% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 $272,335,000 +$121,754,000 +81% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $150,581,000 +$107,743,000 +252% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $42,838,000 +$36,698,000 +598% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $6,140,000 +$6,069,000 +8548% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
2017 $71,000 -$6,863,000 -99% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $6,934,000 -$5,841,000 -46% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $12,775,000 01 Jan 2015 31 Dec 2015 10-K 05 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.